We are live on ! Find out more
NXTC icon

NextCure
NXTC

43 hedge funds and large institutions have $19.6M invested in NextCure in 2023 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 13 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

7% more capital invested

Capital invested by funds: $18.4M → $19.6M (+$1.22M)

0.04% less ownership

Funds ownership: 4.02% → 3.98% (-0.04%)

4% less funds holding

Funds holding: 45 → 43 (-2)

29% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 7

54% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 13

Holders
43
Holders Change
-2
Holders Change %
-4.44%
% of All Funds
0.69%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
6
Reduced
13
Closed
7
Calls
$231K
Puts
–
Net Calls
+$231K
Net Calls Change
+$75K

Top Buyers

Rank Fund Capital Flow
1
TCM
Tang Capital Management
California
+$642K
2
BCM
BML Capital Management
Indiana
+$492K
3
Millennium Management
Millennium Management
New York
+$188K
4
Morgan Stanley
Morgan Stanley
New York
+$141K
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$93K

Top Sellers

Rank Fund Capital Flow
1
CPA
Cardiff Park Advisors
California
-$369K
2
Goldman Sachs
Goldman Sachs
New York
-$347K
3
Renaissance Technologies
Renaissance Technologies
New York
-$260K
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$199K
5
BlackRock
BlackRock
New York
-$196K
Name Holding Trade Value Shares
Change 		Change in
Stake
O
1
OrbiMed
New York
$4.01M – – –
SI
2
Sofinnova Investments
California
$3.95M – – –
Millennium Management
3
Millennium Management
New York
$2.15M +$188K +9,752 +9%
BlackRock
4
BlackRock
New York
$1.37M -$196K -10,196 -12%
Vanguard Group
5
Vanguard Group
Pennsylvania
$1.34M – – –
LFCM
6
Long Focus Capital Management
Puerto Rico
$823K – – –
Acadian Asset Management
7
Acadian Asset Management
Massachusetts
$721K +$93K +4,831 +13%
Citadel Advisors
8
Citadel Advisors
Florida
$710K -$67.9K -3,527 -8%
TCM
9
Tang Capital Management
California
$592K +$642K +33,333 New
Federated Hermes
10
Federated Hermes
Pennsylvania
$575K -$713 -37 -0.1%
BCM
11
BML Capital Management
Indiana
$454K +$492K +25,539 New
Renaissance Technologies
12
Renaissance Technologies
New York
$362K -$260K -13,507 -40%
Dimensional Fund Advisors
13
Dimensional Fund Advisors
Texas
$304K -$199K -10,326 -38%
DCM
14
DAFNA Capital Management
California
$278K – – –
Geode Capital Management
15
Geode Capital Management
Massachusetts
$249K – – –
Macquarie Group
16
Macquarie Group
Australia
$222K – – –
SCM
17
Sio Capital Management
New York
$192K – – –
Morgan Stanley
18
Morgan Stanley
New York
$175K +$141K +7,332 +290%
Two Sigma Advisers
19
Two Sigma Advisers
New York
$158K -$57K -2,958 -25%
BCM
20
Bridgeway Capital Management
Texas
$140K -$80.2K -4,167 -35%
Goldman Sachs
21
Goldman Sachs
New York
$138K -$347K -18,022 -70%
Barclays
22
Barclays
United Kingdom
$100K -$19 -1 -0%
State Street
23
State Street
Massachusetts
$84.5K – – –
Norges Bank
24
Norges Bank
Norway
$76.8K – – –
MAM
25
Marquette Asset Management
Minnesota
$76.1K +$82.5K +4,285 New
1
2

NXTC Hedge Fund Activity: Q1 2023 in Review

43 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in NextCure (NXTC) for Q1 2023, worth a combined $19.6M — up 6.6% from $18.4M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of NXTC and 5 opened new positions — a net loss of 2 holders — while 13 trimmed existing stakes and 6 added.

The largest buyer was Tang Capital Management, opening a new position worth an estimated $642K. The largest seller was Cardiff Park Advisors, exiting entirely with an estimated $369K sold.

  • 43 institutional investors held NextCure (NXTC) as of Q1 2023, down from 45 in Q4 2022.
  • Funds reported $19.6M of NextCure stock for Q1 2023, up 6.6% quarter-over-quarter.
  • 5 funds opened new NextCure positions in Q1 2023 and 7 closed out, a net change of -2 holders.
  • The largest NextCure buyer in Q1 2023 was Tang Capital Management, an estimated $642K added.
  • The largest NextCure seller in Q1 2023 was Cardiff Park Advisors, an estimated $369K sold.

Based on aggregated 13F filings for Q1 2023.